Is Famciclovir Safe While Breastfeeding?
Famciclovir passes into breast milk in small amounts, but limited data suggests low risk for most breastfed infants when used short-term at standard doses for herpes infections. The manufacturer states it's unknown if famciclovir is excreted in human milk, advising caution.[1] Studies show penciclovir (its active metabolite) reaches milk levels of about 0.21 mg/L after a 500 mg maternal dose, resulting in an infant dose of roughly 0.08 mg/kg/day—less than 1% of the typical therapeutic infant dose.[2]
What Do Experts Recommend?
The American Academy of Pediatrics considers famciclovir compatible with breastfeeding due to low systemic absorption in infants. LactMed (NIH) rates it as "probably compatible," noting no adverse effects reported in limited cases, and recommends monitoring the infant for unusual irritability or diarrhea.[2] UK NICE guidelines allow it during breastfeeding for treating herpes zoster or simplex, preferring it over valacyclovir in some scenarios due to similar low transfer.[3]
How Much Gets into Breast Milk?
After a single 500 mg dose, peak milk penciclovir concentration is 0.21 mg/L, with an average of 0.14 mg/L over 4 hours. For a 500 mg twice-daily regimen, estimated infant exposure is 31 mcg/kg/day—far below antiviral treatment doses for infants (typically 60 mg/kg/day).[2] Milk-to-plasma ratio is about 0.21-0.54, indicating minimal transfer.[4]
Are There Risks for the Infant?
No serious adverse events linked to famciclovir exposure via breast milk in available case reports or studies. Theoretical risks include mild GI upset or rash, but these are unconfirmed. Premature or very young infants (<2 weeks) may need closer monitoring due to immature kidney function, as penciclovir is renally cleared.[2][5] One study of 12 women found no changes in infant growth or development after maternal use.[4]
What If I Need to Take It Long-Term?
Short courses (e.g., 7 days for shingles) pose negligible risk. For suppression therapy (e.g., recurrent genital herpes, 250 mg twice daily), data is scarcer—experts suggest pumping and discarding milk for 24-48 hours post-dose if concerned, though not strictly necessary.[2] Consult a doctor to weigh benefits against alternatives.
Better Alternatives While Breastfeeding?
Acyclovir is preferred first-line (0.6 mg/L in milk, relative infant dose <0.1%) with more safety data.[2] Valacyclovir transfers similarly to famciclovir but converts to acyclovir. Both have extensive breastfeeding evidence. Avoid if possible during first month postpartum without medical advice.[3][5]
[1]: Famciclovir Prescribing Information (FDA)
[2]: LactMed: Famciclovir (NIH)
[3]: UK NICE: Antiviral Treatment in Pregnancy and Breastfeeding
[4]: Drugs and Lactation Database (PubMed)
[5]: MotherToBaby Fact Sheet: Antivirals